Home › Stocks › VRNA

Verona Pharma plc (VRNA): insider buying, hedge funds & Congress trades

Verona Pharma plc (VRNA): 3 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Nov 18, 2024Ebsworth David R
Director
20,000$4.44$88.8Kno history
Nov 7, 2024Ackermann Christina
Director
41,880$4.74$198.5Kno history
Nov 7, 2024Ebsworth David R
Director
39,360$4.80$188.9Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for VRNA

Free account. Know when insiders, famous funds or Congress trade it.

Start free